stockrow
Friday 6 November 2026
Export NSYS’s income statement to Excel — free account
Nortech Systems Incorporated
NSYS Healthcare Medical Devices
Nortech Systems Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $118.4 million, down 7.62% from fiscal 2024.
- Revenue
- +9.34%
- EPS
- −8.33%
- Free cash flow
- −1,567.2%
- Total debt
- −79.0%
Quarter to June 2026, against a year earlier
11.20
0.70
+6.67%
Follow NSYS
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 4.04 | 15.83 | 3.86 | 0.00 | 0.00 | 50.71 | 0.00 | 377.00 |
Piotroski F-Score |
5 | 1 | 6 | 6 | 6 | 5 | 5 | 7 | 5 | 6 |
P/S ratio |
0.17 | 0.22 | 0.20 | 0.24 | 0.24 | 0.18 | 0.11 | 0.08 | 0.10 | 0.09 |
Altman Z-Score |
2.79 | 3.10 | 3.37 | 3.32 | 2.96 | 2.58 | 2.60 | 2.65 | 2.83 | 2.91 |
P/FCF ratio |
8.25 | 0.00 | 69.18 | 10.76 | 0.00 | 2.78 | 54.53 | 9.07 | 19.64 | 6.55 |
Altman Z″-Score (non-manufacturers) |
4.24 | 4.76 | 5.09 | 4.33 | 4.25 | 3.03 | 3.00 | 3.30 | 3.21 | 3.42 |
Beneish M-Score |
(2.62) | (2.42) | (2.10) | (2.86) | (1.58) | (2.70) | (2.20) | (2.59) | (2.86) | (2.90) |
P/Operating CF |
3.68 | 35.75 | (66.99) | 7.24 | (16.34) | 13.04 | 10.55 | (79.64) | 56.36 | 6.24 |
P/B ratio |
0.60 | 0.84 | 0.79 | 1.15 | 1.07 | 1.03 | 0.66 | 0.46 | 0.55 | 0.47 |
Price to Tangible BV |
0.60 | 0.84 | 0.79 | 1.16 | 1.09 | 1.10 | 0.81 | 0.56 | 0.70 | 0.61 |
EV/Sales |
0.18 | 0.29 | 0.24 | 0.29 | 0.32 | 0.26 | 0.24 | 0.20 | 0.22 | 0.20 |
EV/EBITDA |
9.28 | 24.48 | 4.17 | 6.61 | 8.73 | 6.84 | 11.24 | 6.76 | 11.71 | 8.14 |
EV/Operating CF |
7.66 | (16.79) | 18.85 | 7.10 | (8.12) | 19.84 | 27.56 | 9.50 | 31.10 | 6.75 |
EV/FCF |
8.40 | (10.50) | 83.58 | 12.95 | (7.00) | 3.94 | 115.46 | 22.04 | 45.74 | 15.09 |
Quick Ratio |
0.63 | 0.74 | 0.79 | 0.80 | 0.99 | 0.98 | 0.86 | 0.85 | 1.01 | 0.88 |
Current Ratio |
1.88 | 2.58 | 2.21 | 2.08 | 2.32 | 2.10 | 1.95 | 1.84 | 2.09 | 1.94 |
Net Debt/EBITDA |
(0.45) | 5.20 | 0.54 | 0.85 | 1.81 | 2.02 | 5.93 | 3.98 | 6.68 | 4.61 |
Debt/Assets |
0.87% | 12.35% | 8.02% | 10.67% | 14.72% | 20.04% | 24.69% | 24.38% | 28.95% | 24.81% |
Debt/Equity |
0.02 | 0.26 | 0.17 | 0.26 | 0.38 | 0.62 | 0.76 | 0.69 | 0.76 | 0.62 |
Asset Turnover |
1.64 | 1.74 | 1.93 | 1.96 | 1.85 | 1.75 | 1.92 | 2.02 | 2.09 | 2.08 |
Operating CF/Net income |
(10.88) | 1.74 | 0.26 | 2.69 | (0.63) | (0.88) | (0.81) | 14.72 | (0.33) | 80.69 |
Capex/Depreciation |
(0.12) | (0.73) | (0.63) | (1.26) | (0.37) | 1.20 | (0.34) | (0.63) | (0.08) | (0.85) |
Interest Coverage |
1.01 | (0.26) | 12.22 | 9.46 | 5.28 | (0.99) | 0.21 | 1.65 | (2.02) | 1.15 |
| (0.74%) | (3.76%) | 21.85% | 7.49% | 32.28% | (8.10%) | (6.05%) | 0.82% | (11.75%) | 0.20% | |
| (0.35%) | (1.76%) | 9.50% | 2.94% | 11.47% | (2.60%) | (2.02%) | 0.30% | (4.55%) | 0.08% | |
ROIC |
1.82% | (0.29%) | 9.37% | 7.36% | 4.21% | (1.44%) | 0.41% | 2.25% | (2.32%) | 1.11% |
Return on Tangible Assets |
(0.80%) | (3.23%) | 17.75% | 5.76% | 20.27% | (5.54%) | (4.01%) | 0.53% | (8.18%) | 0.15% |
Average Days of Receivables |
52.42 | 42.37 | 50.50 | 50.69 | 62.62 | 54.78 | 58.23 | 64.69 | 56.59 | 54.83 |
Research and Development Expense of Revenue |
0.99% | 0.93% | 0.86% | 1.09% | 0.42% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
13.17% | 11.83% | 11.45% | 11.29% | 10.73% | 11.26% | 10.62% | 10.64% | 11.42% | 11.33% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.06 | 0.07 | 0.08 | 0.09 |
Share Based Compensation of Revenue |
0.42% | 0.36% | 0.30% | 0.25% | 0.22% | 0.17% | 0.22% | 0.11% | 0.04% | 0.00% |
Graham Net Nets |
0.91 | 0.60 | 0.69 | 0.42 | 0.39 | 0.11 | 0.14 | 0.73 | 0.51 | 0.61 |
Graham Number |
0.00 | 0.00 | 26.98 | 13.23 | 24.19 | 0.00 | 0.00 | 3.49 | 0.00 | 1.34 |
Earnings Yield |
(1.21%) | (4.57%) | 24.75% | 6.32% | 25.89% | (8.37%) | (9.45%) | 1.97% | (22.85%) | 0.27% |
Free Cash Flow Yield |
12.12% | (12.70%) | 1.45% | 9.29% | (19.11%) | 36.01% | 1.83% | 11.03% | 5.09% | 15.27% |
Revenue per Share |
42.62 | 46.51 | 51.19 | 49.95 | 43.22 | 39.17 | 43.65 | 42.11 | 40.91 | 42.45 |
Operating CF per Share |
0.99 | (0.82) | 0.65 | 2.01 | (1.70) | 0.51 | 0.37 | 0.91 | 0.29 | 1.29 |
Capex per Share |
(0.06) | (0.46) | (0.47) | (0.90) | (0.27) | 2.07 | (0.28) | (0.52) | (0.09) | (0.71) |
Free Cash Flow per Share |
0.93 | (1.28) | 0.18 | 1.11 | (1.98) | 2.58 | 0.09 | 0.39 | 0.20 | 0.58 |
Cash per Share |
0.60 | 0.33 | 0.62 | 0.92 | 0.83 | 1.34 | 0.25 | 0.35 | 0.28 | 0.10 |
Shareholders Equity per Share |
12.44 | 12.34 | 12.98 | 10.46 | 9.80 | 7.04 | 7.50 | 7.83 | 7.22 | 8.12 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
12.44 | 12.34 | 12.98 | 10.46 | 9.80 | 7.04 | 7.50 | 7.83 | 7.22 | 8.12 |
Free Cash Flow |
2.59 | (3.51) | 0.49 | 2.98 | (5.27) | 6.86 | 0.24 | 1.05 | 0.55 | 1.58 |
Working Capital |
26.31 | 33.89 | 32.21 | 28.46 | 29.47 | 21.50 | 21.05 | 20.96 | 19.72 | 19.18 |
Capital Expenditures |
(0.16) | (1.26) | (1.28) | (2.43) | (0.73) | 5.50 | (0.76) | (1.39) | (0.26) | (1.95) |
Net Current Asset Value |
18.78 | 16.89 | 19.01 | 13.40 | 10.79 | 2.12 | 1.85 | 6.99 | 5.51 | 6.29 |
EV/EBIT |
21.54 | 0.00 | 5.60 | 9.86 | 16.23 | 0.00 | 122.68 | 18.60 | 0.00 | 37.63 |
Capex to Sales |
0.00 | 0.01 | 0.01 | 0.02 | 0.01 | (0.05) | 0.01 | 0.01 | 0.00 | 0.02 |
Price to Operating Income |
21.16 | 0.00 | 4.64 | 8.20 | 12.14 | 0.00 | 57.94 | 7.65 | 0.00 | 16.33 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.25 | 0.28 | 0.31 | 0.30 | 0.33 | 0.71 | 0.23 | 0.22 | 0.34 | 0.22 |
Cash ROIC |
7.02% | (8.01%) | 1.13% | 7.84% | (13.79%) | 20.29% | 0.67% | 2.88% | 1.54% | 4.35% |
Accounts Receivable Turnover |
7.43 | 7.50 | 7.35 | 6.99 | 6.51 | 6.09 | 6.02 | 6.04 | 6.43 | 6.43 |
Accounts Payable Turnover |
8.23 | 8.10 | 7.57 | 8.26 | 8.29 | 7.48 | 6.45 | 6.71 | 7.85 | 7.65 |
Inventory Turnover |
4.74 | 5.15 | 5.27 | 5.43 | 5.96 | 6.70 | 6.63 | 5.63 | 5.12 | 5.03 |
Average Days of Payables |
46.59 | 37.94 | 50.01 | 47.51 | 46.72 | 43.44 | 49.30 | 66.18 | 42.61 | 49.10 |
Days of Inventory on Hand |
75.27 | 70.89 | 68.02 | 72.07 | 71.43 | 53.79 | 50.23 | 62.03 | 67.48 | 73.35 |
Average Receivables |
15.94 | 17.08 | 18.95 | 19.19 | 17.69 | 17.09 | 19.33 | 18.76 | 17.47 | 18.13 |
Average Payables |
12.20 | 13.75 | 15.36 | 13.75 | 11.97 | 12.63 | 16.08 | 14.92 | 12.76 | 13.43 |
Average Inventory |
21.17 | 21.65 | 22.05 | 20.94 | 16.68 | 14.10 | 15.64 | 17.77 | 19.59 | 20.42 |
Average Assets |
72.18 | 73.78 | 72.33 | 68.32 | 62.36 | 59.52 | 60.69 | 56.02 | 53.80 | 56.04 |
Average Common Equity |
34.03 | 34.42 | 31.46 | 26.85 | 22.16 | 19.10 | 20.28 | 20.21 | 20.82 | 22.04 |
Columns are period end dates